SKBI - China pharma play, first day on nasdaq - current EPS around $2 (on new share count), expected $3-4 after offering and new share count for 2009/2010 - low float, so respect and look for pullbacks. High margins as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.